House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Obstetrics & Gynaecology · FOGSI

Multifetal pregnancy

FOGSI
B
Source:FOGSI-ICOG Good Clinical Practice Recommendations on Multifetal Pregnancy Management (2024)ISUOG Multiple Pregnancy Practice Guideline (2024)NICE NG137 (2024)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • Monochorionic monoamniotic twins or any monochorionic pregnancy with growth discordance, polyhydramnios/oligohydramnios sequence, or amniotic fluid disparity — twin-to-twin transfusion syndrome; tertiary fetal medicine same-week[1]
  • Threatened preterm labour <34 weeks in twins — admit; corticosteroid; magnesium sulfate for neuroprotection if <32 weeks; tocolysis only to complete steroid course[1]
  • Discordant fetal anomaly or selective intrauterine growth restriction in monochorionic pair — fetal medicine; selective fetoscopic laser or selective termination per legal/ethical framework[1]
  • Severe pre-eclampsia in multifetal pregnancy — admit; deliver as for singleton; multifetal pregnancy increases pre-eclampsia and HELLP risk[1]

First-line treatment

Interventions

  • Chorionicity-driven antenatal pathway[1]
    Dichorionic-diamniotic: scan every 4 weeks from 24, deliver 37–38 weeks. Monochorionic-diamniotic: scan every 2 weeks from 16, deliver 36–37 weeks. Monochorionic-monoamniotic: tertiary surveillance, deliver 32–34 weeks via caesarean
  • Cervical length screening for preterm birth prevention[1]
    Transvaginal cervical length 18–24 weeks; vaginal progesterone 200 mg PO/PV daily for short cervix <25 mm; cerclage selective in twin pregnancies; pessary not routinely indicated
  • Nutritional support and supplementation[1]
    Caloric increase ~300 kcal/day above singleton; calcium 2000–2500 mg/day; iron-folic acid double-dose; vitamin D and B12 per status
  • Mode of delivery[1]
    Vaginal delivery for cephalic-cephalic dichorionic twins with experienced operator; caesarean for non-cephalic first twin, monochorionic-monoamniotic, prior caesarean, or maternal/fetal indication

First-line drug therapy

DrugClassAdultPaediatricNotes
Antenatal corticosteroids[1]Glucocorticoid for fetal lung maturationBetamethasone 12 mg IM × 2 doses 24 h apart, or dexamethasone 6 mg IM × 4 doses 12 h apart—All anticipated preterm twin delivery 24+0 to 34+6 weeks; complete course before delivery if possible; rescue course if delivery delayed >7 days
Magnesium sulfate (neuroprotection)[1]Tocolytic / neuroprotective4 g IV over 20 min, then 1 g/h IV until delivery or 24 h—Anticipated delivery <32 weeks; reduces cerebral palsy risk by ~30% in survivors
Vaginal progesterone[1]Progestogen200 mg vaginal pessary or gel daily from 16–22 weeks until 36 weeks for short cervix—Preterm birth prevention in singleton with short cervix; in twins limited evidence but considered for short cervix; not for routine multifetal use
Aspirin (pre-eclampsia prevention)[1]Antiplatelet (low-dose)150 mg PO at night from 12+0 to 36+0 weeks—All twin pregnancies have elevated pre-eclampsia risk and qualify for prophylaxis
Antenatal corticosteroids[1]
Glucocorticoid for fetal lung maturation
Adult
Betamethasone 12 mg IM × 2 doses 24 h apart, or dexamethasone 6 mg IM × 4 doses 12 h apart
Paediatric
—
All anticipated preterm twin delivery 24+0 to 34+6 weeks; complete course before delivery if possible; rescue course if delivery delayed >7 days
Magnesium sulfate (neuroprotection)[1]
Tocolytic / neuroprotective
Adult
4 g IV over 20 min, then 1 g/h IV until delivery or 24 h
Paediatric
—
Anticipated delivery <32 weeks; reduces cerebral palsy risk by ~30% in survivors
Vaginal progesterone[1]
Progestogen
Adult
200 mg vaginal pessary or gel daily from 16–22 weeks until 36 weeks for short cervix
Paediatric
—
Preterm birth prevention in singleton with short cervix; in twins limited evidence but considered for short cervix; not for routine multifetal use
Aspirin (pre-eclampsia prevention)[1]
Antiplatelet (low-dose)
Adult
150 mg PO at night from 12+0 to 36+0 weeks
Paediatric
—
All twin pregnancies have elevated pre-eclampsia risk and qualify for prophylaxis

Safety-net

  1. Reduced fetal movements in either twin at any gestation — same-day maternity assessment unit; this is harder to detect than in singletons[1]
  2. Sudden weight gain (>2 kg/week), severe leg/face swelling, severe headache or visual change — pre-eclampsia signs warrant same-day review[1]
  3. Attend every growth scan and Doppler appointment; many complications in monochorionic twins are silent and progress quickly[1]

Referral criteria

  • All monochorionic twin pregnanciesTertiary fetal medicine for chorionicity-specific surveillance[1]
  • Suspected TTTS, sIUGR, or selective fetal anomalyTertiary fetal medicine same-week for fetoscopic options[1]
  • Threatened preterm labour or short cervixObstetric admission for steroid and consideration of progesterone, cerclage, or transfer to neonatal-equipped centre[1]
  • Higher-order multiples (triplets+)Tertiary maternal-fetal medicine and consider multifetal reduction counselling per local framework[1]

Clinical summary

Antenatal surveillance, preterm birth prevention, and timing of delivery for twin and higher-order multiple pregnancies stratified by chorionicity.

References

  1. 1.FOGSI-ICOG Good Clinical Practice Recommendations on Multifetal Pregnancy Management (2024); ISUOG Multiple Pregnancy Practice Guideline; NICE NG137 (2024)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References